đź”’ China to make 100m AstraZeneca Covid-19 vaccine doses by Xmas – Wall Street Journal
AstraZeneca will allow a Chinese company to produce 100 million doses of its experimental Covid-19 vaccine for trial in China by the end of 2020.
AstraZeneca will allow a Chinese company to produce 100 million doses of its experimental Covid-19 vaccine for trial in China by the end of 2020.
Magda Wierzycka of disruptive financial services company Sygnia updates us on the status of the Oxford University Covid-19 vaccine and shares her views on important Covid-19 topics, including PANDA data.
In Episode 68 of Inside Covid-19, a rational perspective on the plateauing of coronavirus infections cases in South Africa from Discovery health’s Dr Ryan Noach.
Magda Wierzycka, CEO and co-founder of Sygnia, has agreed to join the new television series of The Apprentice South Africa as the CEO in 2021.
Magda Wierzycka – CEO of Sygnia, bought shares in OSI, a company that transforms patents from Oxford University into viable businesses. OSI has shares in Vaccitech, a company ahead of the race in the Covid-19 vaccine.
Veteran journalist Ed Herbst, meticulously pulls together strands of evidence and expert observations both at the Mpati Commission and beyond, to weave a very different narrative to the one Iqbal Survé’s newspapers have stitched together through commission and omission.
A spying scandal involving former president Jacob Zuma and Russia has erupted, with accusations that Zuma’s friends were spying on businesspeople and others who were critical of state capture and graft.
Sygnia has been approved for a secondary listing on A2X Markets and will list on Thursday, 13 September 2018.
Alec Hogg caught up with Magda Wierzycka in a sweltering London where Sygnia’s founder and CEO is investigating ways to globalise her mushrooming business.
At the very least SAP must now pay back the money. With some hefty penalties an added bonus. Such double standards just have to end.